The Effect of High-Dose Radioiodine Treatment on Lacrimal Gland Function in Patients With Differentiated Thyroid Carcinoma
Authors:
- Hossein MirshekarpourHMHossein Mirshekarpour
- Babak FallahiBFBabak Fallahi
- Mohammad EftekhariMEMohammad Eftekhari
- Mohsen SaghariMSMohsen Saghari
- Davood BeikiDavood Beiki
- Kianoush Ansari-GilaniKAKianoush Ansari-Gilani
- Abbas TakavarATAbbas Takavar
- 1 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 32 (9) , 696-699
Abstract
There are a limited number of case reports confirming the radioiodine (I-131) presence in tears and only a few case reports of lacrimal gland dysfunction after I-131 therapy. This study was designed to clarify whether lacrimal gland function can be affected by I-131 therapy. We studied 100 eyes of 50 patients who had received high doses of I-131 for treatment of differentiated thyroid carcinoma and 100 eyes of 50 age- and sex-matched control individuals without a history of interfering conditions. The exposed group was studied at least 3 months after their last I-131 therapy. Dry eye symptoms and Schirmer test values (wetting level in millimeters per 5 minutes) of an exposed group were compared with those of an unexposed group. Fifty-one percent of the exposed eyes and 50% of the unexposed ones revealed at least 1 of the dry eye symptoms. There was no significant difference in symptoms between 2 groups, except for burning sensation and eye redness, which were significantly higher in the exposed eyes. A lower Schirmer test value was noted in the exposed group, 14.5 +/- 10.8 mm, when compared with that in controls, 18.2 +/- 11.0 mm (P = 0.016), and the relative risk of an abnormal Schirmer test in exposed cases to control group was 1.78 +/- 0.62. Correlation coefficient analysis showed no significant relationship between Schirmer test values and cumulative doses of administered I-131. Reduction in the tear secretion from lacrimal glands is seen after high-dose I-131 therapy; however, their symptoms are no greater than an unexposed population.Keywords
This publication has 7 references indexed in Scilit:
- Nasolacrimal Drainage System Obstruction from Radioactive Iodine Therapy for Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2002
- Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Radioactive contamination of contact lenses during radioiodine therapyNuclear Medicine Communications, 2000
- Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: results from a population based studyAnnals of the Rheumatic Diseases, 1998
- Iodine Metabolism and Thyroid Physiology: Current ConceptsThyroid®, 1997
- Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodineNuclear Medicine Communications, 1996
- Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancerOral Surgery, Oral Medicine, Oral Pathology, 1993